Stem Cell Reports (Feb 2019)

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

  • Angelique di Domenico,
  • Giulia Carola,
  • Carles Calatayud,
  • Meritxell Pons-Espinal,
  • Juan Pablo Muñoz,
  • Yvonne Richaud-Patin,
  • Irene Fernandez-Carasa,
  • Marta Gut,
  • Armida Faella,
  • Janani Parameswaran,
  • Jordi Soriano,
  • Isidro Ferrer,
  • Eduardo Tolosa,
  • Antonio Zorzano,
  • Ana Maria Cuervo,
  • Angel Raya,
  • Antonella Consiglio

Journal volume & issue
Vol. 12, no. 2
pp. 213 – 229

Abstract

Read online

Summary: Parkinson's disease (PD) is associated with the degeneration of ventral midbrain dopaminergic neurons (vmDAns) and the accumulation of toxic α-synuclein. A non-cell-autonomous contribution, in particular of astrocytes, during PD pathogenesis has been suggested by observational studies, but remains to be experimentally tested. Here, we generated induced pluripotent stem cell-derived astrocytes and neurons from familial mutant LRRK2 G2019S PD patients and healthy individuals. Upon co-culture on top of PD astrocytes, control vmDAns displayed morphological signs of neurodegeneration and abnormal, astrocyte-derived α-synuclein accumulation. Conversely, control astrocytes partially prevented the appearance of disease-related phenotypes in PD vmDAns. We additionally identified dysfunctional chaperone-mediated autophagy (CMA), impaired macroautophagy, and progressive α-synuclein accumulation in PD astrocytes. Finally, chemical enhancement of CMA protected PD astrocytes and vmDAns via the clearance of α-synuclein accumulation. Our findings unveil a crucial non-cell-autonomous contribution of astrocytes during PD pathogenesis, and open the path to exploring novel therapeutic strategies aimed at blocking the pathogenic cross talk between neurons and glial cells. : In this article, Consiglio and colleagues show that PD iPSC-derived astrocytes contribute to dopaminergic neurodegeneration, indicating an important role for astrocytes in the pathogenesis of Parkinson's disease. PD astrocytes display dysfunctional chaperone-mediated autophagy (CMA), impaired macroautophagy, and progressive α-synuclein accumulation. In co-culture, PD astrocytes transfer α-synuclein to vmDAns and trigger dopaminergic neuronal cell death that can be rescued by treatment with a chemical enhancement of CMA. Keywords: iPSC, Parkinson's disease, non-cell-autonomous, astrocytes, α-synuclein, LRRK2, CRISPR/Cas9, disease modeling, autophagy, neurodegeneration